title: Atrial arrhythmias after cardiac surgery in patients with diabetes mellitus.
abstract: BACKGROUND
  Postoperative atrial fibrillation (AF) is a common complication of cardiac surgery and has been associated with increased incidence of other complications and increased hospital length of stay (LOS). Prevention of AF is a reasonable clinical goal, and, consequently, many randomized trials have evaluated the effectiveness of pharmacological and non-pharmacological interventions for prevention of AF. To better understand the role of various prophylactic therapies against postoperative AF, a systematic review of evidence from randomized trials was performed.
  
  
  METHODS
  MEDLINE search of English-language reports published between 1966 and July 2005 and a search of references of relevant papers were conducted. Clinical studies on AF after cardiac surgery were selected for this analysis. Relevant clinical information was extracted from selected articles.
  
  
  RESULTS
  Postoperative AF is associated with increased morbidity and mortality and longer, more expensive hospital stays. Prophylactic use of beta-adrenergic blockers reduces the incidence of postoperative AF and should be administered before and after cardiac surgery to all patients without contraindication. Prophylactic amiodarone and atrial overdrive pacing should be considered in patients at high risk for postoperative AF (for example, patients with previous AF or mitral valve surgery). For patients who develop AF after cardiac surgery, a strategy of rhythm management or rate management should be selected. For patients who are hemodynamically unstable or highly symptomatic or who have a contraindication to anticoagulation, rhythm management with electrical cardioversion, amiodarone, or both is preferred. Treatment of the remaining patients should focus on rate control because most will spontaneously revert to sinus rhythm within 6 weeks after discharge. All patients with AF persisting for more than 24 to 48 hours and without contraindication should receive anticoagulation.
  
  
  CONCLUSIONS
  AF frequently complicates cardiac surgery. Many cases can be prevented with appropriate prophylactic therapy. A strategy of rhythm management for symptomatic patients and rate management for all other patients usually results in reversion to sinus rhythm within 6 weeks of discharge.
authors.affiliation: Klinik für Innere Medizin III, Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Vöhrenbacherstrasse 23, 78050 Villingen-Schwenningen. werner.jung@sbk-vs.de
authors.forename: W
authors.initials: W
authors.lastname: Jung
authors.forename: U
authors.initials: U
authors.lastname: Meyerfeldt
authors.forename: R
authors.initials: R
authors.lastname: Birkemeyer
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D003920:Diabetes Mellitus; D004554:Electric Countershock; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000638:Amiodarone